• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Andra medicinska specialiteter
    3. Patologi

    Movement Disorders Prescriber's Guide to Parkinson's Disease

    AvK. Ray Chaudhuri,Peter Jenner

    Häftad, Engelska, 2025

    667 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.

    Produktinformation

    • Utgivningsdatum:2025-02-27
    • Mått:190 x 119 x 34 mm
    • Vikt:562 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:600
    • Förlag:Cambridge University Press
    • ISBN:9781009222617

    Utforska kategorier

    • Patologi inom Medicin
    • Farmakologi inom Medicin
    • Apotek och farmaceuter inom Medicin

    Mer om författaren

    Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King's College Hospital and King's College London and the Director of the Parkinson Foundation International Centre of Excellence at King's College. He is ranked number 1 from the UK in terms of clinical expertise and publications by Expertscape, has over 550 publications and was cited as the most published in nonmotor aspects of Parkinson in a recent bibliometric review in 2024. Professor Peter Jenner is an expert on the pharmacology of drugs and treatment strategies used at all stages of Parkinson's disease. He has been involved in the development and marketing of most of the key therapies. Peter has published over 700 papers on the cause, treatment and cure of Parkinson's disease. Dr Valentina Leta is a neurologist movement disorder specialist interested in infusion therapies and autonomic dysfunction in Parkinson's disease (PD). She has worked as principal/sub-investigator of numerous trials investigating the efficacy and safety of new drugs for PD. Dr Leta has been invited as a faculty at international conferences. She is author of over 55 peer-reviewed papers and book chapters on PD. Ms Shelley Jones is a consultant pharmacist in neurosciences, with over 16 years' experience working with people with Parkinson's and helping them to manage their medications optimally. Shelley has worked in the Parkinson's Centre of Excellence and been involved in publication of book chapters, papers and conference posters. Dr Iro Boura is a neurologist currently working as a Ph.D. research fellow at the Neurology Laboratory, University of Crete and as a movement disorders consultant in the University Hospital of Heraklion, Crete (Greece). She is also affiliated with the Parkinson's Foundation of Centre of Excellence, Kings College Hospital and King's College London (UK).

    Innehållsförteckning

    • Foreword from Professor Chaudhuri; Introduction; Amantadine; Amitriptyline; Apomorphine Infusion; Apomorphine Injection; Apomorphine Sublingual; Botulinum; Citalopram; Clonazepam; Clozapine; Desimpramine; Domperidone; Donepezil; Droxidopa; Entacapone; Fludrocortisone; Glycopyrrolate; Istradefylline; Levodopa benserazide; Levodopa carbidopa; Levodopa carbidopa entacapone intestinal gel; Levodopa carbidopa intestinal gel; Levodopa inhaled; Lubipristone; Macrogol; Melatonin; Memantine; Midodrine; Mirabegron; Mirtazepine; Modafanil; Naltrexone; Nortriptyline; Opicapone; Oxybutynin; Piribedil; Pramipexole; Pimavenserin; Quetiapine; Rasagiline; Rivastigmine; Ropinirole; Rotigotine; Safinamide; Selegiline; Sildenafil; Solifenacin; Tolcapone; Tolterodine; Trihexyphenidyl; Venlafaxine; Zonisamide; Abbreviations.